Literature DB >> 6246688

Hepatitis viruses: characterization and diagnostic techniques.

J L Dienstag.   

Abstract

Two human hypatitis viruses have been identified and characterized, but one or more additional agents exist. Hepatitis B virus (HBV) is a complex 42-nm predominantly double-stranded DNA virus with distinct surface and core antigens and an endogenous DNA polymerase. Hepatitis A virus (HAV) is a 27-nm RNA virus with enterovirus-like properties. Progressively more sensitive and specific immunologic assays have been applied to the study of viral hepatitis and are available for routine diagnostic purposes. As a result we recognize distinct serologic response patterns to infection, new antigenic markers, biochemical-biophysical characteristics of the viruses, and their epidemiologic features. Recombinant DNA technology has permitted the cloning of HBV genetic material and gene products in E. coli, but the virus has not been cultivated in vitro. In contrast, successful in vitro cultivation of HAV has finally been accomplished. Application of sensitive serologic tests for HAV and HBV has revealed that "non-A, non-B" agents account for a substantial proportion of transfusion-associated hepatitis as well as hepatitis occurring in the absence of percutaneous exposure. These agents have been transmitted to chimpanzees, and several putative virus antigen-antibody systems have been described; however, a specific association between these virus antigens and non-A, non-B hepatitis has not been established.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246688      PMCID: PMC2595847     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  52 in total

1.  Transfusion-associated hepatitis not due to viral hepatitis type A or B.

Authors:  S M Feinstone; A Z Kapikian; R H Purcell; H J Alter; P V Holland
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

2.  A specific complement-fixation test for human hepatitis a employing CR326 virus antigen. Diagnosis and epidemiology.

Authors:  P J Provost; O L Ittensohn; V M Villarejos; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

3.  Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578).

Authors:  P J Provost; B S Wolanski; W J Miller; O L Ittensohn; W J McAleer; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

4.  Immunologic distinction between infectious and serum hepatitis.

Authors:  A M Prince; R L Hargrove; W Szmuness; C E Cherubin; V J Fontana; G H Jeffries
Journal:  N Engl J Med       Date:  1970-04-30       Impact factor: 91.245

5.  Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.

Authors:  J J Lander; H J Alter; R H Purcell
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

6.  Detection of Australia antigen by means of immune adherence haemagglutination test.

Authors:  M Mayumi; K Okochi; K Nishioka
Journal:  Vox Sang       Date:  1971-02       Impact factor: 2.144

7.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

8.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

9.  Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

Authors:  S M Feinstone; A Z Kapikian; R H Purceli
Journal:  Science       Date:  1973-12-07       Impact factor: 47.728

10.  Faecal shedding of hepatitis-A antigen.

Authors:  J L Dienstag; S M Feinstone; A Z Kapikian; R H Purcell
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.